SYPLF yields 0.02% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 4
Combined, SYPLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYPLF + JNJ for your $10,000?
Sanyo Special Steel Co., Ltd., together with its subsidiaries, manufactures and sells special steel products in Japan and internationally. The company operates through Steel Materials, Powder Business, Shape Material Business, and Others segments. The Steel Materials segment manufactures and sells various special steel products, such as bearing steel, machine structural steel, stainless steel, heat resistant steel, and tool steel. The Powder Business segment manufactures and sells metal powder products. The Shape Material Business manufactures and sells raw material products made from special steel bars and pipes. The Others segment provides information processing services for the steel materials, powder, and raw material businesses. The company's steel products are used in a range of automobiles, railways, construction machinery, electronics products, and information and communication equipment. The company was formerly known as Sanyo Steel Works and changed its name to Sanyo Special Steel Co., Ltd. in 1959. The company was founded in 1933 and is headquartered in Himeji, Japan. Sanyo Special Steel Co., Ltd. operates as a subsidiary of Nippon Steel Corporation.
Full SYPLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.